Definigen Competitors and Similar CompaniesClear all

Definigen's competitors and similar companies include SUN bioscience, Mirimus, Sana Biotechnology and Editas Medicine.

	Definigen Definigen is a company that provides functional disease model human cells, including hepatocytes, pancreatic beta cells, and intestinal organoids.	SUN bioscience SUN bioscience is a biotech company engineering industry-standard organoids.	Mirimus Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.	Sana Biotechnology Sana Biotechnology is a company specializing in cell and gene therapy.	Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Founding Date	Founding Date 2012	Founding Date 2016	Founding Date 2010	Founding Date 2018	Founding Date 2013
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare bioengineering biotech genetics	Tags Healthcare biotech clinical research pharma	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics	Tags Healthcare bioengineering biotech genetics
Locations	Locations Babraham, GB HQ	Locations Lausanne, CH HQ	Locations Brooklyn, US HQ	Locations Seattle, US HQ Cambridge, US South San Francisco, US	Locations Cambridge, US HQ Boulder, US Cambridge, US
Employees	Employees 26	Employees 109% decrease	Employees 633% decrease	Employees 42110% increase	Employees 20816% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 840.9 m	Valuation ($) 256.5 m
Financial
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($266.8m) (FY, 2024)	Net income ($237.1m) (FY, 2024)
Funding
Latest funding round	Latest funding round $ 886.8k (over 6 years ago)	Latest funding round N/A	Latest funding round $ 2m (about 14 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 9.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 700m	Total funding raised $ 210m